These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 25715023

  • 21. [Management of patients with bradykinin-mediated angioedema in oral and maxillofacial surgery].
    Rohart J, Bouillet L, Moizan H.
    J Stomatol Oral Maxillofac Surg; 2017 Apr; 118(2):109-114. PubMed ID: 28345520
    [Abstract] [Full Text] [Related]

  • 22. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
    Zanichelli A, Wu MA, Andreoli A, Mansi M, Cicardi M.
    Expert Opin Drug Saf; 2015 Apr; 14(11):1725-36. PubMed ID: 26429506
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Evaluation and management of angioedema of the head and neck.
    Bas M, Hoffmann TK, Kojda G.
    Curr Opin Otolaryngol Head Neck Surg; 2006 Jun; 14(3):170-5. PubMed ID: 16728895
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
    Craig TJ, Bernstein JA, Farkas H, Bouillet L, Boccon-Gibod I.
    Int Arch Allergy Immunol; 2014 Jun; 165(2):119-27. PubMed ID: 25401373
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial.
    Javaud N, Fain O, Durand-Zaleski I, Launay D, Bouillet L, Gompel A, Sobel A, Woimant M, Rabetrano H, Petrovic T, Lapostolle F, Boccon-Gibod I, Reuter PG, Bertrand P, Mezaour M, Coppere B, Floccard B, Kanny G, Baker E, Martin L, Vicaut E, Adnet F.
    Ann Emerg Med; 2018 Aug; 72(2):194-203.e1. PubMed ID: 29503044
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Managing hereditary angioedema patients undergoing otolaryngeal procedures.
    Bernstein JA.
    Am J Rhinol Allergy; 2013 Aug; 27(6):522-7. PubMed ID: 23866957
    [Abstract] [Full Text] [Related]

  • 34. Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency.
    Zanichelli A, Mansi M, Periti G, Cicardi M.
    Expert Rev Clin Immunol; 2013 May; 9(5):477-88. PubMed ID: 23634741
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Icatibant as acute treatment for hereditary angioedema in adults.
    Farkas H.
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):779-88. PubMed ID: 27123689
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Angiotensin-converting enzyme inhibitor-induced angioedema--a dangerous new epidemic.
    Rasmussen ER, Mey K, Bygum A.
    Acta Derm Venereol; 2014 May; 94(3):260-4. PubMed ID: 24285044
    [Abstract] [Full Text] [Related]

  • 40. [Diagnosis of hereditary angioedema].
    Bouillet L.
    Presse Med; 2015 Jan; 44(1):52-6. PubMed ID: 25511656
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.